AMY GORDON: Open Payments
NPI 1164798989 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 20 payments from 9 companies in 2025. Trend: 2023 $778 · 2024 $987 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $171 |
| Travere Therapeutics, Inc. | 3 | $170 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $157 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Calliditas Therapeutics US Inc. | 1 | $14 |
Products named: Kerendia, KRYSTEXXA, Filspari, JARDIANCE, JYNARQUE, ULTOMIRIS, PURIFIED CORTROPHIN GEL, TAVNEOS.
Industry payments across TX — which companies pay providers there.
